MedPath

Paraxib

Brand Name: Paraxib

Generic Name: Parecoxib (As Sodium)

Active
Registration Number

DRP-13338

Dosage Form

Lyophilized Powder for Injection (IM/IV)

Issuance Date

August 7, 2024

Expiry Date

March 23, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg
Packaging5 mL Type I Clear Glass Vial Sealed with Bromobutyl Rubber Stopper and Aluminum Flip-Off Seal Cap x 1's (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Selective Cox-2 Inhibitor (Coxib)
A
Application
Initial (Reconstruction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Parecoxib (As Sodium)Active
Monograph: parecoxib (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform